- Home
- NBXG vs GPCR Comparison
NBXG vs GPCR Comparison
Compare NBXG & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBXG
- GPCR
- Stock Information
- Founded
- NBXG 2021
- GPCR 2016
- Country
- NBXG United States
- GPCR United States
- Employees
- NBXG N/A
- GPCR N/A
- Industry
- NBXG Trusts Except Educational Religious and Charitable
- GPCR
- Sector
- NBXG Finance
- GPCR
- Exchange
- NBXG Nasdaq
- GPCR Nasdaq
- Market Cap
- NBXG 1.1B
- GPCR 1.2B
- IPO Year
- NBXG N/A
- GPCR 2023
- Fundamental
- Price
- NBXG $15.22
- GPCR $30.60
- Analyst Decision
- NBXG
- GPCR Strong Buy
- Analyst Count
- NBXG 0
- GPCR 8
- Target Price
- NBXG N/A
- GPCR $69.57
- AVG Volume (30 Days)
- NBXG 243.7K
- GPCR 914.1K
- Earning Date
- NBXG 01-01-0001
- GPCR 11-13-2025
- Dividend Yield
- NBXG 10.25%
- GPCR N/A
- EPS Growth
- NBXG N/A
- GPCR N/A
- EPS
- NBXG N/A
- GPCR N/A
- Revenue
- NBXG N/A
- GPCR N/A
- Revenue This Year
- NBXG N/A
- GPCR N/A
- Revenue Next Year
- NBXG N/A
- GPCR N/A
- P/E Ratio
- NBXG N/A
- GPCR N/A
- Revenue Growth
- NBXG N/A
- GPCR N/A
- 52 Week Low
- NBXG $9.31
- GPCR $13.22
- 52 Week High
- NBXG $12.23
- GPCR $42.57
- Technical
- Relative Strength Index (RSI)
- NBXG 54.88
- GPCR 65.79
- Support Level
- NBXG $15.11
- GPCR $25.59
- Resistance Level
- NBXG $15.53
- GPCR $27.49
- Average True Range (ATR)
- NBXG 0.23
- GPCR 1.42
- MACD
- NBXG 0.02
- GPCR -0.05
- Stochastic Oscillator
- NBXG 67.37
- GPCR 91.17
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.